Highlights Applied DNA Sciences, Inc.

Equities

APDN

US03815U4094

Delayed Nasdaq Other stock markets 03:23:05 2024-05-21 pm EDT			5-day change	1st Jan Change
1.951 ^USD	-0.46%		-39.44%	-84.19%

May. 14	Maxim Downgrades Applied DNA Sciences to Hold From Buy	MT
May. 13	Top Premarket Decliners	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Premarket Decliners	May. 13	MT
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q2 Revenue $929,631	May. 10	MT
Applied DNA Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 10	CI
Applied DNA Sciences Regains Nasdaq Minimum Bid Price Requirement	May. 10	MT
Banned Chinese cotton found in 19% of US retailers' merchandise, study shows	May. 07	RE
Applied DNA Sciences, Inc. Receives Contract by HDT Bio for Rapid Vaccine Development Program	Apr. 25	CI
Reverse Split: 1 of 20	Apr. 24	FA
Applied DNA Sciences, Inc. to Showcase Linea DNA and Linea IVT Platforms At 24Th Annual World Vaccine Congress	Mar. 14	CI
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q1 Revenue $891,164	Feb. 08	MT
Applied DNA Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 08	CI
Applied DNA Sciences, Inc. Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology?s mRNA Manufacturing Workflow	Dec. 14	CI
Earnings Flash (APDN) APPLIED DNA SCIENCES Posts Q4 Revenue $779,736, vs. Street Est of $1.7M	Dec. 07	MT
Applied DNA Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	Dec. 07	CI
Applied DNA Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Dec. 07	CI
Applied DNA Sciences, Inc. Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application	Nov. 28	CI
Applied DNA Sciences, Inc. Extends Application of Linea(Tm) Ivt Platform to Sna (Self-Amplifying Mrna)	Nov. 16	CI
Applied DNA Sciences, Inc. Advances Commercialization of Linea(TM) IVT Platform	23-09-06	CI
Applied DNA Sciences, Inc. Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit	23-08-29	CI
Applied DNA Sciences, Inc. Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production	23-08-23	CI
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q3 Revenue $2.9M, vs. Street Est of $2.56M	23-08-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Applied DNA Sciences, Inc.

Equities

APDN

US03815U4094

Highlights

Filters